APLM vs REGN: Which Stock is Better?
Side-by-side comparison of Apollomics Inc and Regeneron Pharmaceuticals Inc in 2026
APLM
Apollomics Inc
$14.27
REGN
Regeneron Pharmaceuticals Inc
$753.93
Key Metrics Comparison
| Metric | APLM | REGN | Winner |
|---|---|---|---|
| Market Cap | $32.64M | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | 3.8% | 0.0% | APLM |
| Gross Margin | 100.0% | 44.6% | APLM |
Analyze APLM
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APLM or REGN a better investment?
Comparing APLM and REGN: Apollomics Inc has a market cap of $32.64M while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APLM and REGN?
APLM (Apollomics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APLM or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APLM or REGN?
APLM has higher revenue growth at 3.8% vs 0.0% for REGN.
Which company is more profitable: APLM or REGN?
Apollomics Inc (APLM) has higher gross margins at 100.0% compared to 44.6% for REGN.
Which is the larger company: APLM or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $32.64M for APLM.
Should I buy APLM or REGN in 2026?
Both APLM and REGN have investment merit. APLM trades at $14.27 while REGN trades at $753.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APLM and REGN stock?
Key differences: Market Cap ($32.64M vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (3.8% vs 0.0%), Gross Margin (100.0% vs 44.6%).